Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Teva reaches opioid settlement, Credit Suisse names new CEO, Twitter to hold shareholder vote - YouTube
Teva Pharmaceuticals on Twitter: "Teva Global Operations NA and Complex Manufacturing Finance Leader Mayra Avila shares how she confronted a challenge head-on to find her voice. Read her story and learn more
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva workers blockade Jerusalem industrial park as PM, CEO set to meet | The Times of Israel
Teva profit plummets, stock slides | Ctech
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
Teva workers threaten to blow up Jerusalem factory in protest over layoffs | The Times of Israel
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook
High Debt, Potential Litigation Costs Face New Teva CFO - WSJ
Teva Seeks New CFO as It Faces High Debt Levels, Opioid Litigation - WSJ
Teva (TEVA) Beats on Q3 Earnings, Lags Sales, Shares Up
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
Teva Reports Third Quarter 2022 Financial Results
Teva responds to Mylan backlash with planned launch of generic EpiPen | Healthcare Finance News
Jose Lassalle - Finance Manager - Teva Pharmaceuticals | LinkedIn
Teva Reports Fourth Quarter and Full Year 2020 Financial Results | Business Wire
Teva Announces $2,250,000,000 Debt Tender Offers for Notes Due 2023-2026 | Business Wire
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Teva Pharmaceuticals Industries Ltd. to buy Rimsa for $2.3 billion - Pittsburgh Business Times
Teva shares approach 20-year low amid Moody's warning and other woes | Fierce Pharma